Ipilimumab vs Moxifloxacin
Ipilimumab vs Moxifloxacin: Overview
This comparison examines the pharmacological differences between Ipilimumab and Moxifloxacin.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Moxifloxacin: Fourth-generation fluoroquinolone inhibiting DNA gyrase and topoisomerase IV with enhanced anaerobic activity.
Pharmacokinetics
Half-life: Ipilimumab — 14.7 days; Moxifloxacin — 12 hours.
Chemical Properties
Molecular Formula: Moxifloxacin — C21H24FN3O4.
Molecular Weight: Moxifloxacin — 401.4350 g/mol.
Type: Ipilimumab — Antibody; Moxifloxacin — Small molecule.